Meghmani Organics is buzzing in trade; it's up 150 percent in the last six months. In an interview to CNBC-TV18, Kaushal Soparkar, MD of the company spoke about the latest happenings and his outlook going ahead.

Will maintain EBITDA & margin in pigment segment: Meghmani Organics

In an interview to CNBC-TV18, Ashish Soparkar, MD of Meghmani Organics spoke about the latest happenings in the company and his outlook going ahead.

Margins will go up as we ramp up capacity: Meghmani Organics

Sunidhi Securities initiated coverage with a buy rating on Meghmani Organics. In an interview to CNBC-TV18, Ashish Soparkar, MD of Meghmani Organics spoke about the latest happenings in his company and sector.

Chloromethane plant to be commissioned in Q4FY18: Meghmani Org

In an interview to CNBC-TV18, Ashish Soparkar, MD of Meghmani Organics said that chloromethane plant will be commissioned in Q4 of FY18.

Expect topline growth of Rs 300 cr in FY17: Meghmani Organics

Soparkar expects the company's topline to grow by Rs 300-350 crore in FY17 and an additional Rs 350 crore in FY18.

Meghmani Organics gets nod for technical product in US

In an interview to CNBC-TV18, the company‘s Managing Director Ashish Soparkar said that the company will have 15-20 percent of market size for the technical product.

Bharuch plant to add Rs 125 cr revenue to business: Meghmani

The expected earnings before interest, tax, depreciation and amortisation (EBITDA) for the new plant at Bharuch is expected at around 30 percent, says Natwarlal M Patel, managing director of Meghmani Organics.

China chemicals slowdown to benefit biz: Meghmani

In an interview with CNBC-TV18, Natu Patel, MD of Meghmani Organics, discussed the recent slowdown in the Chinese speciality chemicals market and what it means for Indian companies such as his.

Will fund Dahej plant via internal accruals: Meghmani

The company currently is sitting on a land bank of 2.7 million square feet at Sanand but has not plans of monetising it, said Ashish Soparkar, MD, Meghmani Organics.

Meghmani Organics JV with Japanese cos to fructify in 2014

Meghmani Organics has announced a joint venture with two Japan-based companies to produce resins for chlorinated polyvinyl chloride (CPVC), which is currently imported from US and Japan.

Meghmani Organics eyes sales target of Rs 1200 cr for FY12

Speaking to CNBC-TV18, Ashish Soparkar, managing director of Meghmani Organics, said that the Panoli plant is fully operational and the company hopes that the board and government will take positive action in the coming week, giving a green signal to the plant operations.

Meghmani Organics cheers govt nod to allow FDI in seed biz

The government has allowed foreign direct investment in the development and production of seeds. In an interview with CNBC-TV18, Ashish Soparkar, MD, Meghmani Organics says, this is a good news for the company.